OptiNose Operating Income

OptiNose (OPTN) currently reports a operating income of $-16M as of March 2025. That compares with $-16M in the prior-year period — up 3.8% year over year. Use the charts on this page to explore OptiNose's operating income history and peer comparisons.

OptiNose's operating income increased from $-16M to $-16M — a 3.8% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OptiNose reported $-16M in operating income as of March 2025. That compares with $-16M in the prior-year period — up 3.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OptiNose, and consider following OPTN for alerts when major investors trade the stock.

OptiNose is classified in the Healthcare sector. On operating income, it currently shows $-16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPTN with unrelated industries.